224 related articles for article (PubMed ID: 1330346)
1. Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine.
Diwan BA; Lubet RA; Ward JM; Hrabie JA; Rice JM
Carcinogenesis; 1992 Oct; 13(10):1893-901. PubMed ID: 1330346
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B.
Diwan BA; Henneman JR; Rice JM; Nims RW
Carcinogenesis; 1996 Jan; 17(1):37-43. PubMed ID: 8565134
[TBL] [Abstract][Full Text] [Related]
3. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice.
Diwan BA; Rice JM; Ohshima M; Ward JM
Carcinogenesis; 1986 Feb; 7(2):215-20. PubMed ID: 3948311
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis by phentoin in male F344/NCr rats at a dose causing maximal induction of CYP2B.
Diwan BA; Henneman JR; Nims RW
Int J Toxicol; 2001; 20(2):81-7. PubMed ID: 11354469
[TBL] [Abstract][Full Text] [Related]
5. Promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in mouse hepatocarcinogenesis.
Dragani TA; Manenti G; Galliani G; Della Porta G
Carcinogenesis; 1985 Feb; 6(2):225-8. PubMed ID: 3971489
[TBL] [Abstract][Full Text] [Related]
6. Promotion of malignant 'embryonal' liver tumors by phenobarbital: increased incidence and shortened latency of hepatoblastomas in (DBA/2 x C57BL/6)F1 mice initiated with N-nitrosodiethylamine.
Diwan BA; Ward JM; Rice JM
Carcinogenesis; 1989 Jul; 10(7):1345-8. PubMed ID: 2472233
[TBL] [Abstract][Full Text] [Related]
7. Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice.
Beebe LE; Fornwald LW; Diwan BA; Anver MR; Anderson LM
Cancer Res; 1995 Nov; 55(21):4875-80. PubMed ID: 7585523
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzne (TCPOBOP) in rat and cultured rat hepatocytes.
Nims RW; Sinclair PR; Sinclair JF; Dragnev KH; Jones CR; Mellini DW; Thomas PE; Lubet RA
Xenobiotica; 1993 Dec; 23(12):1411-26. PubMed ID: 7510916
[TBL] [Abstract][Full Text] [Related]
9. The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses.
Lijinsky W; Kovatch RM; Thomas BJ
Carcinogenesis; 1992 Jul; 13(7):1293-7. PubMed ID: 1638702
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters.
Diwan BA; Ward JM; Anderson LM; Hagiwara A; Rice JM
Toxicol Appl Pharmacol; 1986 Nov; 86(2):298-307. PubMed ID: 3787627
[TBL] [Abstract][Full Text] [Related]
11. Effects of cytochrome P-450 monooxygenase inducers on mouse hepatic microsomal metabolism of testosterone and alkoxyresorufins.
Kelley M; Womack J; Safe S
Biochem Pharmacol; 1990 Jun; 39(12):1991-8. PubMed ID: 2353939
[TBL] [Abstract][Full Text] [Related]
12. Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbital.
Diwan BA; Ward JM; Kurata Y; Rice JM
Toxicol Pathol; 1994; 22(4):430-9. PubMed ID: 7817132
[TBL] [Abstract][Full Text] [Related]
13. Lack of promoting effect of clonazepam on the development of N-nitrosodiethylamine-initiated hepatocellular tumors in mice is correlated with its inability to inhibit cell-to-cell communication in mouse hepatocytes.
Diwan BA; Lubet RA; Nims RW; Klaunig JE; Weghorst CM; Henneman JR; Ward JM; Rice JM
Carcinogenesis; 1989 Sep; 10(9):1719-24. PubMed ID: 2766464
[TBL] [Abstract][Full Text] [Related]
14. Tumor promotion by an anticonvulsant agent, phenytoin, in mouse liver: correlation with CYP2B induction.
Diwan BA; Henneman JR; Nims RW; Rice JM
Carcinogenesis; 1993 Nov; 14(11):2227-31. PubMed ID: 8242847
[TBL] [Abstract][Full Text] [Related]
15. Effects of the oxazolidinedione anticonvulsants trimethadione and dimethadione and the barbiturate homolog 5,5-dimethylbarbituric acid on N-nitrosodiethylamine-initiated renal and hepatic carcinogenesis in the F344/NCr rat.
Diwan BA; Nims RW; Henneman JR; Ward JM; Lubet RA; Rice JM
Arch Toxicol; 1992; 66(6):413-22. PubMed ID: 1444806
[TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes.
Dragani TA; Manenti G; Della Porta G
J Cancer Res Clin Oncol; 1987; 113(3):223-9. PubMed ID: 3584213
[TBL] [Abstract][Full Text] [Related]
17. Mouse hepatic cytochrome P-450 isozyme induction by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, pyrazole, and phenobarbital.
Raunio H; Kojo A; Juvonen R; Honkakoski P; Järvinen P; Lang MA; Vähäkangas K; Gelboin HV; Park SS; Pelkonen O
Biochem Pharmacol; 1988 Nov; 37(21):4141-7. PubMed ID: 2903743
[TBL] [Abstract][Full Text] [Related]
18. Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium, and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine.
Diwan BA; Rice JM; Ohshima M; Ward JM; Dove LF
J Natl Cancer Inst; 1985 Feb; 74(2):509-16. PubMed ID: 3856057
[TBL] [Abstract][Full Text] [Related]
19. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of the hepatic effects in mice and rats of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a hepatic neoplasm promoter.
Romano M; Esteve A; Coccia P; Masturzo P; Galliani G; Ghezzi P; Salmona M
Toxicol Appl Pharmacol; 1986 Apr; 83(2):379-85. PubMed ID: 3485839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
